Pangaea Data, (Pangaea), provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, today announced that it has been named “Digital Solution of the Year” by the UK Government’s Department for International Trade, as part of its 2023 UK Life Science Innovator Showcase. UK DIT selected Pangaea for this award from thousands of UK companies across the life science industry as a direct result of its international growth and innovative approach to tackling healthcare challenges.
- Pangaea is one of six category winners, selected from thousands of UK companies
- Pangaea will be showcasing its product at the UK pavilion during the Arab Health 2023 Conference in Dubai, from 30th Jan – 2nd Feb 2023
- British embassies around the globe will be showcasing Pangaea’s AI-driven product platform throughout the year
This award follows Pangaea’s selection by the UK DIT as a Leading Digital Health Innovator, and inclusion in the UK government’s Digital Health Playbook for the second consecutive year. The UK Digital Health Playbook showcases the top UK innovators and exporters, providing solutions for current challenges in digital health, including scaling the power of AI for improved diagnoses and more accurate predictions.1
Pangaea’s AI-driven product, Pangaea’s Intelligence Extraction and Summarization (PIES), characterizes patients by mapping their journeys and disease trajectories in an evolving, federated privacy-preserving and scalable manner, which is critical for preventative health and precision medicine. This is achieved by PIES unlocking and summarizing clinically actionable intelligence from patient records, which has proven to find 22 times more undiagnosed, miscoded and at-risk patients; match patients to five times more suitable clinical trials and therapies; discover new relationships between drugs, features and adverse events; predict prognosis; halve treatment costs; and save 90% in costs and time compared to manual and alternative natural language processing (NLP)- based methods.
Dr Vibhor Gupta, CEO and Founder of Pangaea, said: “We are proud to have been selected by DIT for this award, which highlights the value we have created for both patients and clinicians through our novel AI-driven product, which will be critical in realizing the promise of preventative health and precision medicine across the healthcare and pharmaceutical industry. This is also a testament to our proven track-record of success and collaboration, as well as our continued commitment to international expansion.”
Dr Neil Ebenezer, Medical Technology and Genomics Specialist, Department for International Trade, said: “DIT are really pleased to announce the launch of our 2023 UK Life Science Innovator Showcase. These UK companies are at the forefront of life sciences innovation, with solutions that look to deliver on a global scale. DIT are pleased to announce Pangaea as the category winner for Digital Solutions. Pangaea uses existing patient data to provide deeper insights that may allow healthcare professionals to improve patient treatment pathways. We were impressed with their novel AI-driven product that has a proven track record in improving healthcare outcomes.”
